Management of blood pressure in children

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 3, 2012, Pages 318-322

  Malatesta Muncher, Rossana ^a   Mitsnefes, Mark M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

children; hypertension; management

Indexed keywords

CALCIFEDIOL; ENALAPRIL; ISRADIPINE; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; OLMESARTAN; VALSARTAN;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; CIGARETTE SMOKING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; FRUIT; GASTROENTERITIS; HEADACHE; HUMAN; HYPERKALEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OBESITY; PARENTAL BEHAVIOR; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEDENTARY LIFESTYLE; SYSTOLIC BLOOD PRESSURE; VEGETABLE;

ADOLESCENT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; HUMANS; HYPERTENSION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84859638186     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328351c415     Document Type: Review

References (25)

1. Zhang YX, Wang SR. Monitoring of blood pressure in overweight and obese children in Shandong, China. Ann Hum Biol 2011; 38:603-607.
2. Durrani AM, Waseem F. Blood pressure distribution and its relation to anthropometric measurements among school children in Aligarh. Indian J Public Health 2011; 55:121-124.
3. Maldonado J, Pereira T, Fernandes R, et al. An approach of hypertension prevalence in a sample of 5381 Portuguese children and adolescents. The AVELEIRA registry. 'Hypertension in children'. Blood Press 2011; 20:153-157.
4. Bancalari R, Diaz C, Martínez-Aguayo A, et al. Prevalence of hypertension in school age children and its association with obesity. Rev Chil 2011; 139:872-879.
5. Steinthorsdottir SD, Eliasdottir SB, Indridason OS, et al. Prevalence of hypertension in 9- to 10-year-old Icelandic school children. J Clin Hypertens (Greenwich) 2011; 13:774-779.
6. Leung LC, Sung RY, So HK, et al. Prevalence and risk factors for hypertension in Hong Kong Chinese adolescents: waist circumference predicts hypertension, exercise decreases risk. Arch Dis Child 2011; 96:804-809.
7. Khang YH, Lynch JW. Exploring determinants of secular decreases in childhood blood pressure and hypertension. Circulation 2011; 124:397-405. In contrast to other population-based epidemiological studies of BP in children, this study showed significant decrease in prevalence of hypertension and prehypertension over the past 10 years. Interestingly, the improvement in BP was not associated with BMI or physical activity.
8. Ricke TL, Hendry PL, Kalynych C, et al. Incidence and recognition of elevated triage blood pressure in the pediatric emergency department. Pediatr Emerg Care 2011; 27:922-927. The study emphasizes a poor recognition of elevated BP in the setting of the emergency room.
9. Simonetti GD, Schwertz R, Klett M, et al. Determinants of blood pressure in preschool children: the role of parental smoking. Circulation 2011; 123:292-298. The study is the most comprehensive analysis of risk factors associated with elevated BP in preschool children. Special emphasis is on association of hypertension with second-hand smoking.
10. Brady TM, Fivush B, Parekh RS, et al. Racial differences among children with primary hypertension. Pediatrics 2010; 126:931-937.
11. Tu W, Eckert GJ, DiMeglio LA, et al. Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension 2011; 58:818-824. The study showed the effect of overweight on BP levels in children. Most important finding is that the negative effect of increased BMI begins in children who are mildly overweight.
12. Pacifico L, Anania C, Osborn JF, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011; 165:603-611.
13. Aglony M, Martínez-Aguayo A, Carvajal CA, et al. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. Hypertension 2011; 57:1117-1121. The study showed unusually high prevalence of familial hyperaldosteronism in children with elevated BP. They also comment on significant variability in clinical presentation of the affected children.
14. Duncan AF, Heyney RJ, Morgan JS, et al. Elevated systolic blood pressure in preterm very-low-birth-weight infants
15. Blowey DL, Duda PJ, Stokes P, et al. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens 2011; 5:478-483.
16. Damasceno MM, de Araujo MF, de Freitas RW, et al. The association between blood pressure in adolescents and the consumption of fruits, vegetables and fruit juice: an exploratory study. J Clin Nurs 2011; 20:1553-1560.
17. Aatola H, Koivistoinen T, Hutri-Kahonen N, et al. Lifetime fruit and vegetable consumption and arterial pulse wave velocity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 2010; 122:2521-2528. The study confirms that low fruit and vegetable intake during childhood is associated with increased arterial stiffness in young adulthood.
18. Tsioufis C, Kyvelou S, Tsiachris D, et al. Relation between physical activity and blood pressure levels in young Greek adolescents: the Leontio Lyceum Study. Eur J Public Health 2011; 21:63-68.
19. Maggio AB, Aggoun Y, Martin XE, et al. Long-term follow-up of cardiovascular risk factors after exercise training in obese children. Int J Pediatr Obes 2011; 6:e603-e610.
20. Hazan L, Hernandez Rodriguez OA, Bhorat AE, et al. A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension. Hypertension 2010; 55:1323-1330. In this study important information about safety and efficacy of olmesartan in children is provided.
21. Wells T, Blumer J, Meyers KE, et al. Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension. J Clin Hypertens (Greenwich) 2011; 13:357-365. In this study important information about safety and efficacy of valsartan in children is provided.
22. Schaefer F, Litwin M, Zachwieja J, et al. Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study. J Hypertens 2011; 29:2484-2490.
23. Miyashita Y, Peterson D, Rees JM, et al. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens (Greenwich) 2010; 12:850-855.
24. Thomas CA, Moffett BS, Wagner JL, et al. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 2011; 12:28-32.
25. Litwin M, Niemirska A, Sladowska-Kozlowska J, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol 2010; 25:2489-2499.